Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.40 per share
-
Shares outstanding
-
23.6M
-
Number of holders
-
114
-
Total 13F shares, excl. options
-
176M
-
Shares change
-
+59M
-
Total reported value, excl. options
-
$1.12B
-
Value change
-
+$376M
-
Put/Call ratio
-
0.42
-
Number of buys
-
69
-
Number of sells
-
-31
-
Price
-
$6.38
Significant Holders of Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) as of Q1 2024
124 filings reported holding AUTL - Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share as of Q1 2024.
Autolus Therapeutics plc - Ordinary Shares, par value NIS 0.40 per share (AUTL) has 114 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 176M shares
.
Largest 10 shareholders include Syncona Portfolio Ltd (21.3M shares), Blackstone Inc. (20.5M shares), Deep Track Capital, LP (15.3M shares), Avoro Capital Advisors LLC (12.3M shares), WELLINGTON MANAGEMENT GROUP LLP (10.8M shares), FMR LLC (9.02M shares), TFG Asset Management GP Ltd (7.53M shares), Cormorant Asset Management, LP (6.62M shares), Paradigm Biocapital Advisors LP (6.43M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (5.49M shares).
This table shows the top 114 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.